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Phosphorylated p38 (pp38) mitogen-activated protein kinase
(MAPK) regulates heat shock protein 25 (HSP25), stabilizing
fibrillar actin (FA) and preventing cleavage to G-actin (GA).
Cultured podocytes (Pods) were exposed to glucose
(5.5–50 mM)7p38MAPK inhibitor SB202190 (SB) or control
SB202474 to assess the effects on FA/GA and Pod structure.
The relationship of p38MAPK with in vivo Pod structure and
albuminuria (Ualb) was assessed in rats with streptozotocin
(SZ)-induced diabetes (DM) for 1 week, 1 month, and 4
months. High glucose induced concentration-dependent
increases in pp38MAPK and phosphorylated HSP25 (pHSP25)
maintained actin cytoskeleton. Inhibition by SB diminished
pp38MAPK and pHSP25, decreased FA/GA, and altered FA
and GA immunohistochemical appearance. In SZ-DM,
glomerular pp38MAPK and biphosphorylated HSP25 were
increased after 1 week, declining at 1 month, and at or below
C values at 4 months. Glomerular FA/GA in DM was normal
at 1 week, declining at 1 month, and low at 4 months.
Ualb/creatinine was similar in DM vs C at 1 week, and
increased at 1 and 4 months. Morphometry demonstrated
progressively diminishing slit pore density in DM over time,
denoting evolving effacement. There were strong
correlations between slit membrane density and both
glomerular biphosphorylated HSP25 and ln Ualb/cr ratio.
The data suggest that increased pp38MAPK and pHSP25
comprise an acute adaptation to glycemic stress. Later
depletion of DM may contribute to Pod structural alterations
and Ualb.
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Diabetic complications are induced by chronic glycemic
exposure engendering a state of oxidative and carbonyl
stress1–3 and signaling pathway activation, culminating in
extracellular matrix synthesis, glomerulosclerosis, and tubu-
lointerstitial fibrosis.4–12 Protective cellular responses are
poorly understood and focus on antioxidant defenses.13–15
Little is known about how injurious and protective processes
interact to contribute to the development of the proteinuria.
The podocyte (Pod) is a major participant in the
maintenance of glomerular size selectivity, and both experi-
mental and clinical mutations in structural Pod proteins
induce proteinuria.16 There are limited genetic data directly
linking mutations in signaling molecules and/or nuclear
transcription factors to the development of proteinuria, such
as mutations of the nuclear transcription factor LMX1B in
nail-patella syndrome.17 Mutations in the mitogen-activated
protein kinase (MAPK) signaling pathway have not to date
been implicated in the development of proteinuria. Never-
theless, the potential for MAPK involvement in glomerular
permselectivity via its role in signaling mediation in the
Pod remains. We and others previously reported an early
increase in glomerular phosphorylated p38 (pp38) MAPK in
streptozotocin-induced diabetic nephropathy (SZ DN) in the
rat.6,9,10 This was associated with maintenance of normoal-
buminuria in diabetic rats for up to 2 months.9 At 4 months
diabetes (DM) duration, pp38MAPK regressed to the control
value, accompanied by albuminuria (Ualb).9 These data
suggested that early upregulation of the p38MAPK path-
way might protect against the development of Ualb, and,
conversely, that regression might predispose to Ualb.
The p38MAPK signaling pathway lies upstream to and
regulates activation of the small heat shock protein 25
(HSP25), the mouse homolog of the corresponding human
protein, HSP27. HSP25 binds to and stabilizes actin
cytoskeletal filaments,18–20 maintaining cell shape. In Pods,
cell shape can be disrupted experimentally by exposure to the
aminonucleoside of puromycin (PAN),21 which, in vivo, is
associated with proteinuria. In in vitro and in vivo models of
Pod injury induced by PAN, HSP25 levels increased.21
Upregulation of HSP25 by transfection with sense cDNA in
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cultured Pods protected the actin cytoskeleton against PAN-
induced injury, whereas no protection was observed in
antisense or vector-transfected cells.22 Thus, a relationship
between HSP25, cytoskeletal structure, and proteinuria has
been established in Pods in response to acute injury induced
by a chemical toxin.21,22 Its role in mediating DN has not
been examined in detail.
In these experiments, we demonstrate a role for the
p38MAPK–HSP25 signaling pathway in the maintenance of
the Pod actin cytoskeleton in response to acute glycemic
stress in vitro. An in vivo relationship between early glome-
rular upregulation of p38MAPK and HSP25 phosphory-
lation, normal Pod structure, and normoalbuminuria in
early SZ DN also is demonstrated. However, there is late
exhaustion of this adaptive response in vivo, marked by
reversion of pp38MAPK to control levels, and a decrement in
phosphorylated heat shock protein 25 (pHSP25), accompa-
nied by the onset of Pod effacement, and Ualb.
RESULTS
In vitro cell culture studies
Short-term in vitro exposure of Pods to high glucose (HG)
media induces concentration-dependent phosphorylation of
p38MAPK and HSP25, and is associated with actin
cytoskeletal preservation.
After differentiation and 24 h of serum starvation, Pods
were exposed to either glucose 5.5–50 or 5.5 mM glucose
corrected to iso-osmolarity with mannitol for 10 min prior to
cell protein harvest. A representative Western immunoblot
demonstrates a linear increase in the pp38/p38MAPK ratio
across glucose concentrations from 5.5 to 50 mM (Figure 1a).
Figure 1b and c show that there is a concomitant increment
in HSP25 biphosphorylation demonstrated by isoelectric
focusing (IEF). Total and monophosphorylated HSP25 were
not significantly changed (not shown). Pods in short-term
HG maintained normal cytoskeleton, shown in a representa-
tive photomicrograph stained with Texas red phalloidin
showing F-actin filaments (Figure 1d), and nuclear DNA
staining, but very few cytoplasmic G-actin (GA) monomers
stained with Oregon green DNase I (Figure 1e), find-
ings similar to those observed in cells incubated in Roswell
Park Memorial Institute (RPMI) with 5.5 mM glucose. These
data demonstrate a linear relationship between medium
glucose content and p38 activation, yielding down-
stream HSP25 phosphorylation and actin cytoskeletal main-
tenance.
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Figure 1 | Dose-dependent activation of p38MAPK, phosphorylation of small HSP25, and maintenance of normal Pod cytoskeleton
after short-term exposure of Pods to HG in culture. Differentiated Pods placed for 24 h in 0.4% fetal bovine serum were treated with
indicated concentrations of glucose and/or mannitol (in triplicate) for 10 min before lysates were prepared for sodium dodecyl sulfate-
polyacrylamide gel electrophoresis, IEF, and subsequent Western blot analysis with anti-phospho p38MAPK antibody, p38MAPK antibody, and
anti-HSP25 antibody. (a) Representative Western blots of phospho-specific p38MAPK (pp38MAPK) and quantitative evaluation of relative
pp38MAPK to total p38MAPK (p38) ratios by densitometry analysis. (b, c) Representative IEF, Western blot analysis of HSP25, and quantitative
evaluation of relative phosphorylated HSP25 isoforms to total HSP25 ratios by densitometry analysis. By using IEF, HSP25 can be separated into
its nonphosphorylated isoform (P0), mono- (P1), and bi-phosphorylated (P2) isoforms. With incremental glucose concentrations, there is a
relative increase in the phosphorylated HSP25 isoforms ((b) (P1þ P2)/total HSP25), especially (c) the biphosphorylated form (P2/total HSP25).
pp38MAPK and P2HSP25 did not change when mannitol was used as a control for osmolarity. (d, e) Differentiated Pods seeded on coverslips
were exposed to HG and followed by fixation for staining. The cytoskeleton in HG-treated cells was similar to NG-treated cells. A representative
photomicrograph stained with Texas red phalloidin showing normal F-actin filaments (d) and nuclear DNA staining, with very few cytoplasmic
GA monomers stained with Oregon green DNase I (e). *Po0.05, **Po0.01, versus 5.5 mM glucose control.
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HG, but not high osmolarity, increases pp38MAPK
and pHSP25 (Figure 1a and b). Incubation of Pods with
SB202190 (SB) in both normal glucose (NG) and HG media
inhibits p38MAPK and HSP25 phosphorylation, and is
associated with actin cytoskeleton disruption.
Pods cultured for 10 min in 25 mM glucose (HG) increased
pp38 (Figure 2a), pHSP25 (Figure 2b), and filamentous to
monomeric globular (F/G)-actin ratio (Figure 2c) compared
to Pods cultured in 5.5 mM glucose (NG) and Pods cultured
with an additional 19.5 mM mannitol (NGþM) to maintain
iso-osmolarity. Incubation of Pods in HG with the phospho-
p38MAPK inhibitor SB (HGþ I) induced a decrement in p38
(Figure 2a) and HSP25 phosphorylation (Figure 2b), and in
F/G ratio (Figure 2c). Pods in HGþ control inhibitor (IC)
SB202474 were similar to HG alone (Figure 2a–c). Repre-
sentative photomicrographs showed clumped F-actin fila-
ments in HGþ I (Figure 2d), which were fewer in number
compared to IC. DNase I staining was present in cyto-
plasm in HGþ I, demonstrating cleavage of F-actin to GA
monomers (Figure 2d). These data demonstrate a specific,
non-osmotic, mechanistic relationship between HG and
p38MAPK–HSP25 pathway activation in the maintenance
and preservation of the Pod actin cytoskeleton.
In vivo animal studies
SZ-DM for 1 week is characterized by Ualb in DM similar to
controls, increased p38MAPK and HSP25 phosphorylation,
glomerular F- and G-actin maintenance, and slit membrane
density preservation. Blood glucose levels at killing were
11872 mg/dl in C and 388721 in DM (Po109). There was
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Figure 2 | Effect of p38MAPK inhibitor SB on p38MAPK activation, HSP25 phosphorylation, F/G-actin ratio, and Pod cytoskeleton in
Pods cultured in NG and HG. Differentiated Pods were exposed to HG (25 mM) for 10 min without pre-exposure (HG) or with 4 h of pre-
exposure (HGþ I) to the p38MAPK inhibitor SB. SB202474 was used as an inhibitor control (HGþ IC). Mannitol was added to NG (5.5 mM, NG)
media as an osmolarity control (NGþM). (a) Representative Western blots of phospho-specific p38MAPK with or without SB and quantitative
evaluation of relative pp38MAPK to total p38MAPK ratios by densitometry analysis. *Po0.05, HG versus NG, HGþ I versus NG. (b)
Representative IEF gel, Western blots of HSP25 with or without SB, and quantitative evaluation of relative phosphorylated HSP25 isoforms to
total HSP25 ratios ((P1þ P2)/(P0þ P1þ P2)) by densitometry analysis. The same samples used in (a) were centrifuged and resuspended in urea
buffer; 30 mg protein of each sample was subjected to Bio-Rad Model 111 mini-IEF cell cast gel and subsequent Western blotting to detect the
different phosphorylated HSP25 isoforms using the antibody against HSP25. The right two lanes are controls, in which Pod lysates were
prepared before (Podo) and after (PodoþHS) heat shock stress. *Po0.05: NG versus HG; NGþM versus HG; NG versus HGþ IC; NGþM versus
HGþ IC. **Po0.01: NG versus HGþ I; NGþM versus HGþ I; HG versus HGþ I; HGþ IC versus HGþ I. (c) GA and total cellular actin were
measured on the same samples as those in (a), using a DNase I assay to determine F/G actin ratios. *Po0.05: NG versus HG; NGþM versus HG;
NG versus HGþ I; HGþ IC versus HGþ I; **Po0.01: HG versus HGþ I. (d) Differentiated Pods seeded on coverslips were exposed to HG or
HGþ I, fixed, and stained. As shown in Figure 1d and e, Pods incubated in HG without inhibitor maintain normal staining of speculated F-actin
fibrils and only very few cytoplasmic GA staining. In Pods incubated with HGþ I, a representative photomicrograph stained with Texas red
phalloidin shows disrupted F-actin filaments and representative photomicrograph stained with Oregon green DNase I shows diffuse
cytoplasmic GA monomers. The expected binding to nuclear DNA is also observed.
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no significant increment in Ualb/cr ratio in the DM com-
pared to C rats (P¼ 0.29). There was a 1.7-fold statistically
significant increase in the pp38MAPK/total p38MAPK ratio
(Figure 3a). Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was not significantly different. The increased
pp38/total p38MAPK ratio was accompanied by increased
HSP25 biphosphorylation (Po0.05) (Figure 3c). Total and
monophosphorylated HSP25 were not significantly different
(not shown). Activation of p38MAPK and HSP25 signaling
was associated with actin cytoskeleton maintenance, shown
by preservation of the glomerular F/G-actin ratio (Figure 3d),
and stable glomerular actin/GAPDH, assessed by immuno-
blotting (not shown). There were 20273 slit membranes/
100 mm of glomerular basement membrane (GBM) in C
(n¼ 9) and 19074 in DM (n¼ 3, P¼ 0.052) (Figure 4a).
These data reveal associations between activation of the
p38MAPK and HSP25 signaling pathways in acute DM,
maintenance of the actin cytoskeleton, and the beginning of a
numerical decline in filtration slit membrane density and an
increment in Ualb, neither of which reaches statistical signi-
ficance. The data demonstrate a process that may be viewed
as an acute adaptation to glycemic stress, which is barely
maintaining normal glomerular structure and function.
SZ-DM for 1 month is characterized by an intermediate
response in evolving DN, characterized by the advent of Ualb,
continued elevations in p38MAPK and HSP25 phosphoryla-
tion levels compared to controls (albeit declining compared
to 1 week), glomerular F- and G-actin maintenance, but
significantly diminished slit membrane density (Figures 3a–d
and 4a). The blood glucose level was 7872 mg/dl in C and
334732 in DM (Po104). Ualb continued to be two-fold
higher than C, now statistically significant (Po0.05). There
was a 1.6-fold increase in the pp38MAPK/total p38MAPK
ratio compared to C (Figure 3a), which was numerically, but
not statistically, lower than the 1.7-fold increment observed
at 1 week in the DM group. GAPDH was not significantly
different. There was a 58% decline in biphosphorylated
HSP25 compared to that observed in rats with DM for
1 week, but this change was not significant (Figure 3c), and
overall the value remained almost 10-fold higher than in C
rats. Total HSP25 and monophosphorylated HSP25 were not
different (not shown). Continued activation of the p38MAPK
and HSP25 signaling pathways at 1 month in the DM group
was associated with glomerular F/G-actin ratio that was
similar to the C group, although there was a numerical trend
toward a lower value than that observed at 1 week of DM
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Figure 3 | Glomerular expression of pp38MAPK, each of the two phosphorylated HSP25 isoforms, and F/GA ratios in 1-week, 1-month,
and 4-month C and SZ-DM rats. (a) Representative Western blots of glomerular pp38MAPK from SZ-DM and C rats and quantitative
evaluation of relative pp38MAPK to total p38MAPK ratios by densitometry analysis. *Po0.05: DM versus control. (b) The upper panel consists of
representative Western blots of a mini-IEF from sieved glomeruli at the indicated time points from SZ-DM and C rats. The right two lanes are
positive controls using samples with (PodoþHS) or without (Podo) heat shock stress. The bottom figure and (c) are quantitative densitometry
analyses of relative phosphorylated HSP25 (P1þ P2) and biphosphorylated HSP25 isoform (P2) to total HSP25 (P0þ P1þ P2) ratios,
respectively. *Po0.05. (d) GA and total cellular actin were measured on the same samples as those in (a), using a DNase I assay to determine
F/G-actin ratios. *Po0.05.
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(Figure 3d). Glomerular actin/GAPDH assessed by immuno-
blotting also was not different in DM rats from C (not
shown). Finally, the filtration slit membrane density was
20273 in C and 16476 in DM (n¼ 4) (Po0.05) (Figure
4a). These data describe an intermediate phenotype, during
which time a signaling adaptation continues to be expressed.
This adaptation is characterized by the maintenance of
increased, albeit numerically declining, levels of pp38MAPK
and biphosphorylated HSP25 compared to that observed
after 1 week of DM. These elevated, but downward-trending,
values are associated with maintenance of the glomerular
F/G-actin ratio in DM, although it, too, is declining relative
to the values observed at 1 week. Finally, these changes are
associated with a small, but significant, decline in the number
of filtration slit membranes along the GBM. These changes
reflect a period during which an acute adaptive process that
maintains Pod structure and function in the face of glycemic
stress begins to fail.
SZ-DM for 4 months is characterized by frank Ualb,
reversion to control values of pp38MAPK, lower values of
biphosphorylated HSP25, diminished glomerular F- com-
pared to G-actin, and a further decrement in Pod slit
membrane density (Figures 3a–d and 4a). The blood glucose
level in the C group was 6072 mg/dl and in DM was
303712 mg/dl (Po104). There was a significant five-fold
increase in Ualb in the DM rats compared to C (Po104).
The increment in the pp38/total p38MAPK ratio observed at
1 week and 1 month was unsustained, reverting to control
levels (Figure 3a). Biphosphorylated HSP25 in the DM
group declined to 36% of the C value (Po0.05) (Figure 3c)
and the glomerular F/G-actin ratio declined to 43% of the
C value (Po0.05) (Figure 3d). Glomerular actin/GAPDH
assessed by immunoblotting was not different in DM
and C rats (data not shown). The density of glomerular
slit membranes was lower in DM 13777 (n¼ 5) than C
20273 (Po0.01), consistent with developing effacement
(Figure 4a).
Correlations
There was an inverse correlation between the ln Ualb/cr
ratio and glomerular biphosphorylated HSP25 levels in the
DM rats (r¼0.43, P¼ 0.03) (Figure 4b). These data
demonstrate that this relationship is more clearly observed
in stressed (e.g. DM) than in unstressed (e.g. C) rats. The
ln Ualb/cr ratio also correlated negatively with slit membrane
density (r¼0.72, P¼ 0.0003) (Figure 4c), underscoring
an inverse relationship between biphosphorylated HSP25
levels and the number of slit membranes. HSP25 levels
were measured on pooled glomerular samples from 3–5 rats,
and the slit membranes were counted on a representative
rat whose glucose was closest to the mean value for that
cohort. There was a strong correlation (r¼ 0.92) between
the biphosphorylated HSP25 level measured on the pooled
sample and the slit membrane density from the tissue
of the representative rat from the cohort (P¼ 0.0004)
(Figure 4d).
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Figure 4 | The number of slit membranes per 100 lm of GBM, and relationship analysis between Ualb/cr ratio and glomerular p2HSP25
levels, Ualb/cr ratio and glomerular slit pore frequency, the p2HSP25 level and the slit membrane frequency in 1-week, 1-month, and
4-month control and SZ-DM rat glomeruli. (a) A sequential decline in slit membrane number occurs with increasing duration of DM
(*Po0.05: DM 4 months vs DM 1 week, DM 4 months vs DM 1 month; #Po0.01: DM 4 months vs Control, DM 1 month vs control). (b) A strong
inverse correlation was found between the ln Ualb/cr ratios of SZ-DM rats and glomerular biphosphorylated HSP25 (p2HSP25) levels. r¼0.43,
P¼ 0.03. (c) A strong inverse correlation was noted between the ln Ualb/cr ratio and the number of slit membranes per 100 mm of GBM in
control and DM rats. r¼0.72, P¼ 0.0003. (d) A strong positive correlation was noted between the glomerular p2HSP25 level measured on a
pooled sample of glomeruli from four rats (eight kidneys) for each data point and the slit membrane frequency measured on the tissue of a
single rat from each of the four pooled cohorts whose glucose approximated the average of the group. (Each data point represents n¼ 4
P2HSP25 measurements from eight kidneys and slit membrane density measurements derived from one kidney from that group.) r¼ 0.93,
P¼ 0.0004.
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DISCUSSION
We and others showed that, in SZ-DM, glomerular
pp38MAPK is upregulated for up to 2 months after DM
induction.6,9,10 Our previous work also showed that by 4
months, glomerular pp38MAPK values approach control
levels, despite continued hyperglycemia.9,10 Reversion toward
control values was associated with increasing Ualb. The
current study shows that in Pods in vitro, glucose, in a
dose-dependent fashion, upregulates phosphorylation of
p38MAPK and HSP25. The p38MAPK inhibitor SB, but
not its inactive control SB202470, inhibits the phosphoryla-
tion of p38MAPK and downstream HSP25, and facilitates
actin cytoskeleton disruption under physiological and HG
conditions. This study demonstrates a glucose-stimulated
signaling pathway regulating the Pod actin cytoskeleton.
This study also demonstrates that, in the SZ-DM rat,
early activation of glomerular p38MAPK is associated with
increased biphosphorylation of HSP25, maintenance of actin
cytoskeleton, and normoalbuminuria, while late regression
of p38MAPK/HSP25 pathway activation is associated with
glomerular F/G-actin ratio alteration, Pod effacement, and
Ualb. There was a strong positive correlation between
biphosphorylated HSP25 and slit membrane density, and a
strong inverse correlation between biphosphorylated HSP25
and Ualb. These data suggest that Ualb in the SZ-DM rat may
represent exhaustion of an intrinsic adaptive process invol-
ving the p38MAPK–HSP25 signaling pathway. This inter-
pretation implies that DN reflects a balance between
aggregate glycemic injury and the ability of susceptible
tissues to utilize and maintain inherent protective pathways.
Our previous work showed activation of p38MAPK, mito-
gen-activated kinase kinase 3 and 6, and CREB, leading to
extracellular matrix synthesis.9,10 Taken together, the data
show that DM and HG media in vitro upregulate signaling
pathways involving p38MAPK, which simultaneously medi-
ate maladaptive processes leading to increased extracellular
matrix accretion, and adaptive processes leading to actin
cytoskeletal stabilization. Optimal modulation to inhibit the
maladaptive and enhance the adaptive will require either
manipulation of the pathways downstream of p38MAPK or,
possibly, identification of p38MAPK isoforms regulating the
different pathways.
Activated p38MAPK plays a critical adaptive role in
maintaining actin cytoskeleton in response to stressors. In
stressed fibroblasts, p38 stabilized actin via phosphorylated
HSP27,23 a protection abrogated by the p38MAPK inhibitor
SB 203580.23 In cultured umbilical vein endothelium,
hydrogen peroxide activated p38MAPK MAPKAP kinase 2/
3 and HSP27, yielding stress fiber accumulation, vinculin
recruitment to focal adhesions, and loss of membrane ruffles,
responses that were blocked by SB 203580.24 In pancreatic
acini, p38MAPK and HSP27 activation regulated the
cytoskeletal response to cholecystokinin, a response also
abrogated by SB203580.25 In smooth muscle cells, HSP27
colocalized with actin during stimulated contraction.26 In
cultured Pods, transfection with HSP27 sense or antisense
altered the cell’s spreading response to the toxin PAN.22
Phosphorylation of HSP27 by MAPKAP kinase 2/3 induced a
conformational change of the HSP, dissociating actin, and
facilitating the addition of actin monomers and promoting
stress fiber formation.27–33 Finally, in the glomeruli of
rats with SZ-DM for 3 weeks, p38MAPK and HSP25 were
increased, and HSP25 was present as small homo-oligomers
rather than large molecular aggregates.6 Our data are
consistent with the findings in these experiments. The
p38MAPK–HSP25 signaling pathway functioned in a con-
certed fashion in early SZ-DM to preserve the stressed Pod
actin cytoskeleton. Later, pathway regression appears to have
contributed to cytoskeletal disruption and Ualb.
Heat shock proteins are a family with diverse functions
classified according to molecular weight. They are stimulated
by stressors including temperature, hypoxia, ischemia, tumor
necrosis factor, thrombin, fibroblast growth factor, platelet-
derived growth factor, sodium arsenite, glutamate, inter-
leukin-1b, osmolarity, and heavy metals.18,34–36 Large heat
shock proteins act as molecular chaperones, maintaining
protein tertiary conformation and aiding in the removal of
denatured proteins. Large, medium, and small heat shock
proteins inhibit apoptosis in numerous cell types.37–41 Small
heat shock proteins, particularly HSP27, maintain cell
structural integrity by interacting with cytoskeletal actin.
The importance of these proteins is reflected by the
conservation of the amino-acid sequence of the proteins
across species. Nevertheless, there are some important
differences. In humans three phosphorylation sites are
present on HSP27 on serines 15, 78, and 82, whereas in
the rodent homolog there are two phosphorylation sites
(on serines 15 and 86). It remains unclear which properties of
HSP25/27 confer its actin cytoskeletal protection. The size of
the HSP25/27 aggregates,42,43 the state of phosphorylation,
and the total amount of HSP25/27 have all been impli-
cated.44–47 In various cell types, different biochemical features
may predominate in terms of functional importance. In Pods
injured by PAN, experiments did not clearly establish
whether total or phosphorylated HSP25 was the major
mediator of cytoskeletal preservation, but a relationship to
HSP25 was nevertheless demonstrated.22 Our work differs
from that reported by Dunlop and Muggli,6 who measured
an early increase in total HSP25 in SZ-DM. In the study
reported herein, cytoskeletal protection was not associated
with increased total or monophosphorylated HSP25, but was
associated with more biphosphorylated HSP25, suggesting
that, in this setting, increased biphosphorylation may confer
cytoskeletal stabilization. We did not assess HSP oligomeri-
zation. Additional studies will be required to further evaluate
the chemical and molecular features of HSP25 associated
with Pod actin cytoskeleton maintenance in this model.
Furthermore, in these experiments, the direction of glucose
or DM-induced changes in pp38MAPK and HSP25 always
varied in the same direction, but not always by the same
magnitude. This suggests that other signaling molecules
besides p38MAPK regulate HSP25 phosphorylation.
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Thus, these studies are the first to show that glucose
stimulates Pod p38MAPK activation in a dose-dependent
fashion, with downstream activation of HSP25 and preserva-
tion of the actin cytoskeleton in vitro. Inhibition of
p38MAPK phosphorylation inhibited HSP25 activation and
resulted in disruption of actin cytoskeleton at physiological
glucose concentrations and at concentrations plausible in
poorly controlled DM, thus demonstrating a role for
cytoskeletal protection. In SZ-DM in vivo, these studies
demonstrated glomerular p38MAPK and HSP25 activation
during normoalbuminuric DM, but downregulation during
Ualb with associated actin cytoskeletal disruption and Pod
effacement. A significant decrement in the Pod filtration slit
membrane density was associated with Ualb in the diabetic
rats, as is noted in nephrotic patients.48 These studies suggest,
but do not prove, that phosphorylation of p38MAPK and
HSP25 represents an acute adaptation to glycemic stress.
Continued stress results in adaptive escape, appearing to
contribute to Pod structural change and Ualb. The mechan-
isms of putative adaptive escape are not discerned by these
experiments, but may include glycemia-induced alterations
in the structure of the signaling molecules, HSP25 substrate
limitation, or impact of signaling molecules influencing the
pathway apart from those studied herein. Furthermore,
these studies do not rule out the possibility that the late
reduction in the phosphorylation of p38MAPK and HSP25 is
the consequence and not the cause of Ualb. This distinction
can only be made in an experimental model in which
the levels of pp38MAPK and/or HSP27 are directly up- or
downregulated.
MATERIALS AND METHODS
Pod cell culture
Conditionally immortalized mouse Pods were cultured,10,49 except
that we used glucose-free RPMI and added glucose as required. Cells
were serum starved in RPMI with 0.4% fetal bovine serum for 24 h
before each experiment. To demonstrate a dose–response, standard
RPMI with 5.5 mM glucose was maintained or changed to either
5.5 mM glucose plus mannitol for iso-osmolarity or glucose at
concentrations of 20, 25, 30, or 50 mM at the start of each
experiment. Pods were exposed for 10 min, after which cells were
harvested in lysis buffer10 with proteinase and phosphatase inhibitor
cocktails 1 and 2 (Sigma-Aldrich, St Louis, MO, USA) or urea buffer
(9 M urea, 2% nonidet P-40, 0.005% b-mercaptoethanol). Glucose
(25 mM) consistently demonstrated signaling activation and was
used for the subsequent experiments. To demonstrate the mechan-
istic importance of p38MAPK phosphorylation on the maintenance
of phosphorylated HSP25 and its downstream effect on the Pod
actin cytoskeleton, Pods were incubated with or without the
p38MAPK inhibitor (SB) or its control (SB202474) in RPMI
medium as follows: (1) NG (5.5 mM); (2) NGþmannitol (NGþM)
to achieve iso-osmolarity (5.5þ 19.5 mM); (3) HG (25 mM); (4)
NGþ SB (5.5 mMþ2.0 mM); (5) NGþ control SB202474
(5.5 mMþ2.0 mM); (6) HGþ SB (25 mMþ2.0 mM); (7) HGþ control
SB202474 (25 mMþ2.0 mM). In experiments with SB and its inactive
control, preincubation with the SB molecules began 4 h prior to
changing the glucose content and continued throughout the
experiment. Cells were exposed as above with 0.4% fetal bovine
serum for 10 min prior to lysate harvest. Cells cultured identically on
coverslips were examined by immunofluorescence microscopy.
Experimental animals
DM was induced in male Sprague–Dawley rats with SZ as described
previously8–10 (control (C), n¼ 47) or (DM, n¼ 46). Blood glucose
(glucometer) and 24-h urinary albumin (ELISA Nephrat II, Exocell,
Inc., Philadelphia, PA) were measured monthly and prior to killing.
Sieved glomeruli were pooled for protein measurements (generally
from four rats, but three pools were from three rats and two pools
were from five rats). Pooling yielded four control and four diabetic
glomerular samples at each of the time points studied. Kidney
samples were fixed for morphometric measurements.
Western analysis for total and pp38MAPK, and GAPDH
Western immunoblotting was performed as described previously,8–10
except that sieved glomeruli were lysed in RIPA buffer
(1 phosphate-buffered saline, 1% nonidet P-40, 0.5% sodium
deoxycholate, 0.1% sodium dodecyl sulfate, 20 mM sodium fluo-
ride,10 mg/ml phenylmethylsulfonyl fluoride, 10 mM b-glycerophos-
phate , 1 mg/ml leupeptin, and 1 mg/ml aprotinin).
IEF for HSP2521
Pods and glomeruli were solubilized in urea, lysis or RIPA buffers
and stored at 701C. Prior to IEF, samples in lysis and RIPA buffers
were replaced with urea buffer. Protein concentrations were
determined spectrophotometrically (Bio-Rad). All samples were
loaded on a mini-IEF cell (Bio-Rad Model 111, Hercules, CA) cast
gel at 30 mg/well. The gels consist of 4.85% acrylamide, 0.15% bis-
acrylamide, 2% ampholytes (pH 5–7/5–8/3–10¼ 3.5/3/1, Sigma-
Aldrich Co.), 5% glycerol and 6 M urea, polymerized with 0.015%
ammonium persulfate, 0.0005% riboflavin 5-phosphate, and 0.03%
TEMED. Gels were run for 15 min at 100 V, 15 min at 200 V, and at
least 60 min at 450 V, transferred to Whatman 3 MM filter paper,
and electroblotted onto nitrocellulose membranes (Osmonics Inc.,
Minnetonka, MN) overnight at 30 V in transfer buffer containing
0.0375% sodium dodecyl sulfate, 39 mM glycine, and 48 mM Tris.
Membranes were blocked with 5% bovine serum albumin (Santa
Cruz, CA, USA) in Tris-buffered saline/0.2% Tween 20 for 1 h at
room temperature, incubated with 1:10 000 dilution of polyclonal
anti-hsp25 (Stressgen, Victoria, BC, Canada) in blocking solution
for 1 h; washed in Tris-buffered saline/0.2% Tween 20; incubated
with a polyclonal anti-rabbit immunoglobulin G conjugated to
horseradish peroxidase (Cell Signaling, Danvers, MA, USA, 1:5000
dilution for 45 min; re-washed in Tris-buffered saline/0.2% Tween
20; and detected using enhanced chemiluminescence kit (Santa
Cruz). Membranes were exposed to an X-ray film.
Enzymatic measurements of F- and G-actin
Monomeric (G-) and total actin concentrations in Pods and
glomeruli were measured using the GA-dependent DNase I
inhibition assay50 with minor modifications.51 After solubilization
in lysis buffer, 10 ml of lysate was added to 10 ml of DNase I solution
(0.1 mg/ml bovine pancreas DNase I in 50 mM Tris/HCl, 10 mM
phenylmethylsulfonyl fluoride, 0.5 mM CaCl2, pH 7.5) and 1 ml of
DNA solution (40 mg/ml calf thymus DNA type 1 in 100 mM Tris/
HCl, 4 mM MgSO4, 1.8 mM CaCl2, pH 7.5). DNase I activity was
monitored continuously at 260 nm. Actin was measured using a
standard curve for inhibition of DNase I activity using rabbit skeletal
muscle GA (Sigma-Aldrich). Linearity was established between
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25 and 70% inhibition of DNase I activity. For total actin, lysates
were diluted with lysis buffer and incubated on ice with an equal
volume of guanidine/HCl buffer (1.5 M guanidine/HCl, 1 M sodium
acetate, 1 mM CaCl2, 1 mM ATP, 20 mM Tris/HCl, pH 7.5) to
depolymerize
F-actin to monomeric G-actin. F-actin was calculated as the
difference between total and G-actin.
Immunofluorescence microscopy for F- and G-actin
Coverslips with subconfluent differentiated Pods were washed in
phosphate-buffered saline, pH 7.4; fixed in 3.7% formaldehyde for
20 min at room temperature; washed; permeabilized with 0.1%
Triton X-100/phosphate-buffered saline for 10 min; washed; treated
with 1% bovine serum albumin for 30 min to reduce nonspecific
binding; and washed. F- and G-actin were stained concurrently with
fluorescent phallotoxin (Alexa Flour 594 phalloidin, Molecular
Probes/Invitrogen, Carlsbad, CA, USA) and deoxyribonuclease I
conjugate (Oregon Green 488, Molecular Probes); washed;
mounted; air dried; and sealed.
Electron microscopic morphometry
Foot process effacement was assessed by measuring the number of
filtration slit membranes per 100 mm of GBM length. Each animal
evaluated had 30 evenly spaced digitized electron micrographs
of glomerular capillaries from two randomly chosen glomeruli
examined at a final magnification of 19 600 analyzed using Image J
software (NIH, public domain).52
Statistical analysis
Results are expressed as the mean7s.e.m. Statistical analysis was
performed using the statistical packages SPSS for Windows Ver. 7.51
(SPSS, Inc., Chicago, IL) and StatMost (Salt Lake City, UT). For
multiple comparisons, ANOVA was used followed by the least
significance difference test and/or the Kolomorov–Smirnov test.
Significance is assigned at the Po0.05 level.
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